The report titled “Alzheimer’s Disease Diagnostic Market -Forecast to 2022″ is a direct appreciation by Market Research Future of the market potential of the Alzheimer’s Disease Diagnostic Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global market for this is expected to reach USD 12 billion by the end of the forecasted period growing at a CAGR of 10%.
MarketResearchFuture.com adds “Alzheimer’s Disease Diagnostic Market -2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022” reports to its database.
Global Alzheimer’s disease Diagnostic Market – Detailed Regional Analysis:
The regional analysis for Alzheimer market covers regions such as Asia Pacific, North America, Europe and Rest of the World. North America holds the largest market share in global Alzheimer’s disease diagnostic in 2015. The North America Alzheimer’s disease diagnostic market is expected to reach USD 12 Million by the end of the forecast period. Europe is the second-largest market for Alzheimer’s disease diagnostic. Asia Pacific is expected to be fastest growing region of the Alzheimer’s disease diagnostic market.
Global Alzheimer’s disease Diagnostic Market – Global Competitive Analysis:
The sector is considerably undergoing transformation which has enhanced the growth pace of the sector. The industry players in the segment are utilizing their primary resources to initiate a trend of solid, volume-driven growth that has been observed in the market with the development of different varieties of product types. The best long-term growth opportunities for this sector can be harnessed by ensuring ongoing process improvements and maintaining financial flexibility to invest in the optimal strategies. However, with companies aiming to capture a considerable share of the market segment as early as possible, they implementing and experimenting with various advantage points.
Some of the key players in this market are Eli Lilly and Company (UK), TauRx (Republic of Singapore), Alector LLC (US), Accera, Inc. (US), Treventis Corporation (US), Neuro-Bio Ltd (UK), Cognition Therapeutics Inc. (US) and others.
Global Alzheimer’s disease Diagnostic Market – Overview:
Increase in the number of cases detected for Alzheimer’s has been on the rise recently, which has led to the rapid development of its diagnostic market component. Market Research Future, a firm which specializes in market reports related to the healthcare sector among others, recently published a report on this market. The global market for this industry is expected to reach USD 12 billion by the end of the forecasted period while growing at a CAGR of 10% in the forecast period.
Increase in the number of aging population around the world has contributed to the development of this sector. Since the disease cannot be easily detected at its onset, there has been a high level of focus on developing diagnostic tools and procedures to address this concerns. Despite Alzheimer’s being one of the most common neuro degenerative disorders, there is still a significant amount of R & D that has to be conducted to properly address the demand for treatment of this sector.
TRY SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/2149 .
Global Alzheimer’s disease Diagnostic Market – Industry Updates:
Jan 2018 a new class of cyanine compounds that can be used for detection of Alzheimer’s disease was discovered by researchers from Hong Kong Baptist University. The proteins of interest in human’s cerebrospinal fluid are linked to Alzheimer’s disease. The versatile detection assay using the compounds developed by the research team requires only a few microliters of the sample fluids to reliably quantify the target proteins. The detection assay developed by the team is fast, cheaper and more sensitive than traditional commercially available biological methods.
Aug 2017 a student-led team of researchers at Washington University School of Medicine (WUSM) in St. Louis, Missouri, has developed an online app designed to streamline the process of Alzheimer’s disease diagnosis. It provides physicians with more information about patients before they are evaluated in person, enabling physicians to assess and assist patients more quickly. As less time is spent on information gathering to determine a patient’s condition frees up more time for doctors to explain the life-changing implications of an Alzheimer’s diagnosis to patients and their families, and to discuss treatment options.
Sep 2017 Pain Therapeutics has received a $1.8 million research grant from the National Institutes of Health (NIH) to support the development of a technology to diagnose Alzheimer’s disease (AD) in early stages based on a simple blood test. The potential diagnostic blood-test builds on Pain Therapeutics’ PTI-125, a clinical-stage drug candidate for Alzheimer’s.
Nov 2017 Hummingbird Diagnostics, who develops early diagnostics in multiple disease areas, ranging from cancer to cardiovascular and neurodegenerative disease. The company will be working with Andreas Keller and Eckart Meese from the University of Saarland, two renowned experts in miRNA. Under the collaboration agreement, the team will examine at least 5,000 samples to develop tests for severe diseases that include lung cancer, chronic obstructive lung disease (COPD), Alzheimer’s and Parkinson’s.
Global Alzheimer’s disease Diagnostic Market – Industry Segments:
The global Alzheimer’s disease diagnostic market has been segmented on the basis of type which comprises of early-onset Alzheimer’s disease, late-onset Alzheimer’s disease, familial Alzheimer’s disease and more. On the basis of diagnostic tests; the market is segmented into genetic testing, neurological exam, mini-mental state exam (MMSE), brain imaging and others. Lastly, on the basis of end users; the market is segmented into clinics, hospitals, diagnostic centers and others.
AVAIL DISCOUNT @ https://www.marketresearchfuture.com/check-discount/2149 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312